The CWHP report "The Association of Peripheral Artery Disease (PAD) with Work-related Outcomes" presents the results of a study comparing the impact of moderate to severe PAD with mild PAD along with other comorbidities on the incidence and duration of short-term work disability.
This report was partially funded through Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. The views presented in the report are solely the responsibility of the author and do not necessarily represent the views of the sponsoring organization nor collaborators on the study.
If PAD cases can be managed in a way that prevents mild cases from becoming moderate/severe then employees and employers may benefit from less work disruption due to fewer cases of short-term work disability. Key to success is a focus on complex case management and the other comorbidities that these patients may have. By adopting a patient-centered approach to prevention, treatment access and improved outcomes we should expect greater focus on functional and quality of life outcomes that matter to individuals. For those in the workforce, being able to attend work, perform well on the job and stay at work or return to work in a timely and healthy fashion should a period of work disability occur is critical for the continued physical and socioeconomic health of the individual and their contributions to corporate success.